Joseph Edelman's $4.8 billion hedge fund dominated 2019 with 53.7% returns driven by big biotech bets

This is a Business Insider Prime story. Click the link below to read it.

Read Full story

Add Comment()
Comments ()
Sort By:
Be the first one to comment.
We have sent you a verification email. This comment will be published once verification is done.